Tomofusa Fukuyama

Minato, 1088639, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Midbody inheritance predicts re-entry into quiescence, but not lineage potential, in mouse hematopoietic stem cells.

Midbody inheritance predicts re-entry into quiescence, but not lineage potential, in mouse hematopoietic stem cells.

Journal: Experimental hematology

Published: July 30, 2026

Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment.

Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment.

Journal: Cell reports

Published: December 20, 2022

Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia.

Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia.

Journal: Communications biology

Published: September 20, 2022

The E3 ligase DTX2 inhibits RUNX1 function by binding its C terminus and prevents the growth of RUNX1-dependent leukemia cells.

The E3 ligase DTX2 inhibits RUNX1 function by binding its C terminus and prevents the growth of RUNX1-dependent leukemia cells.

Journal: The FEBS journal

Published: September 07, 2022

UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8.

UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8.

Journal: International journal of hematology

Published: January 09, 2022

IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia.

IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia.

Journal: EMBO molecular medicine

Published: December 22, 2021

CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression.

CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression.

Journal: Cancer science

Published: December 07, 2021

MDS cells impair osteolineage differentiation of MSCs via extracellular vesicles to suppress normal hematopoiesis.

MDS cells impair osteolineage differentiation of MSCs via extracellular vesicles to suppress normal hematopoiesis.

Journal: Cell reports

Published: December 06, 2021

Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With MLL Gene Amplification: A Case Report and Literature Review.

Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With MLL Gene Amplification: A Case Report and Literature Review.

Journal: Frontiers in oncology

Published: October 22, 2021

Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors.

Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors.

Journal: Nature communications

Published: May 01, 2021

A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells.

A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells.

Journal: Cell reports

Published: September 08, 2020

Efficacy of tyrosine kinase inhibitors on a mouse chronic myeloid leukemia model and chronic myeloid leukemia stem cells.

Efficacy of tyrosine kinase inhibitors on a mouse chronic myeloid leukemia model and chronic myeloid leukemia stem cells.

Journal: Experimental hematology

Published: August 09, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026